Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum NetraMark Holdings Inc AINMF


Primary Symbol: C.AIAI

NetraMark Holdings Inc. is a Canada-based company, which is focused on the development of Generative Artificial Intelligence (Gen AI)/Machine Learning (ML) solutions targeted at the pharmaceutical industry. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several... see more

CSE:AIAI - Post Discussion

NetraMark Holdings Inc > $MEND.c scientists awarded for research on placebo response
View:
Post by culturedpiggy01 on Jan 05, 2022 1:39pm

$MEND.c scientists awarded for research on placebo response

was reading up on $MEND.c and came across the news that just last month Dr. Joseph Geraci, their chief scientific officer alongside researcher Dr. Robert Morlock, received the International Society for CNS Clinical Trials and Methodology (ISCTM) 2021 Autumn Conference Distinguished Research Award, for their work on placebo response in mental health.
 
they discovered some great findings through their clinical trials like there was a greater proportion of potential placebo (PBO) respondents even in those with lower levels of disease severity. this will allow for more confidence when trying to establish a true signal of efficacy.
 
td, $MEND.c trading at $0.98 with market cap at $39.33 M
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities